He has pioneered non-drug ways to access deeply sacred states of mind usually only available through high doses of sacred medicines. He was co-holder of IND 3250 from the US Food and Drug Administration for the psychotherapeutic use of LSD. He went on to work in Mexico with Salvador Roquet, a Mexican psychedelic psychoanalyst, and Maria Sabina, priestess of the sacred mushrooms, who first disclosed their secret to the west. He has been a pioneer in transpersonal psychology since 1972 when he began his psychedelic research career working with Stanislav Grof as a Research Fellow at Maryland Psychiatric Research Center in Baltimore, Maryland USA. Richard Yensen, Ph.D., is currently administrator and research psychotherapist for the MAPS (Multidisciplinary Association for Psychedelic Studies) sponsored MDMA & PTSD study in Vancouver, BC. This places a unique responsibility on psychotherapy teams and presents a challenge to therapists-how do you protect someone from temporary alterations in their capacity to evaluate reality? These drugs engender a sense of well-being, modify the capacity to feel fear, and create a sense of safety through their pharmacological action. The euphoria often associated with these drugs affects judgment. This happens through a combination of psychedelic and euphoric actions. The unique property of the family of drugs including MDMA and MDA is their ability to enhance rapport and depth in the therapeutic process. This discussion of the strengths and weaknesses of these compounds includes case histories. Dryer will discuss the shortcomings of compounds that affect judgment as therapy aids through the insights gained from their 45 years of experience with these drugs in research psychotherapy settings. June 14, 2016Ĭautionary Tales: MDMA & MDA in Psychotherapy - A Talk with Richard Yensen and Donna Dryer (San Francisco, CA)Įxamine the unique properties that make MDMA and MDA promising candidates for adjuncts to psychotherapy clinical experience. You may safely and confidentially direct misconduct reports related to MAPS-sponsored studies, MAPS staff, MAPS PBC staff, or collaborators to MAPS’ Compliance Team via email or by calling (844) 627-7722. We encourage you to read and follow /safety for detailed information regarding MAPS Code of Ethics for Psychedelic Psychotherapy and our practices to create a culture of safety in psychedelic therapy. Yensen and Dryer are barred from MAPS and MAPS PBC activities, especially providing MAPS-sponsored MAMA-asssisted therapy, due to the ethical violation described in Public Announcement of Ethical Violation by former MAPS-sponsored Investigators.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |